• Return to Headlines

Top 5 Companies in the Biotechnology Industry With the Lowest Free Cash Flow Per Share (SPPI, CYTK, OPK, RGEN, ACOR)

By David Diaz

Below are the three companies in the Biotechnology industry with the lowest (positive) free cash flow per share. FCF/share is a valuable metric signaling a company's ability to facilitate growth in the business.

Spectrum Pharmaceuticals ranks lowest with a FCF per share of $0.10. Following is Cytokinetics with a FCF per share of $0.11. Opko Health ranks third lowest with a FCF per share of $0.31.

Repligen follows with a FCF per share of $0.38, and Acorda Therapeutics rounds out the bottom five with a FCF per share of $0.64.

SmarTrend recommended that its subscribers protect gains by selling shares of Acorda Therapeutics on March 24th, 2017 by issuing a Downtrend alert when the shares were trading at $25.35. Since that call, shares of Acorda Therapeutics have fallen 32.0%. We are now looking for when a new Uptrend will commence and will alert SmarTrend subscribers in real time.

Keywords: lowest free cash flow per share spectrum pharmaceuticals cytokinetics opko health repligen acorda therapeutics

Ticker(s): SPPI CYTK OPK RGEN ACOR